Problem

Hospitals and health systems struggle to adopt clinical AI safely and at scale. AI pilots can stall, while deployment becomes fragmented across Epic plug-ins, vendor models, and in-house imaging tools. The operational pain is especially acute because evaluation, compliance, monitoring, and audit work creates manual administrative overhead and may require additional headcount. The central use case is giving a health system a systematic way to determine which AI tools fill genuine clinical gaps and then manage them throughout their lifecycle.

Product / Service

Parachute is an end-to-end clinical AI governance platform for hospitals. It supports the discovery and vetting of AI tools, runs evaluations, helps deploy models, monitors them for performance drift and compliance, and records decisions in an immutable audit trail. The company positions AI agents as a way to automate the manual grunt work, allowing health systems to govern more AI tools without adding headcount while improving safety, accountability, and scalability.

Market

Parachute competes in the clinical AI governance and healthcare AI infrastructure market, serving hospitals and health systems. Its scope spans third-party clinical software, vendor models, Epic integrations, and internally developed models, making it broader than a point solution focused only on model evaluation or monitoring.

The available research does not identify named competitors or disclose customer traction, revenue, or a definitive pre-revenue status. It does, however, describe Parachute as a portfolio company and characterize its offering as a comprehensive platform addressing stalled pilots and fragmented AI deployment.